Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale
Identifieur interne : 003072 ( Istex/Corpus ); précédent : 003071; suivant : 003073Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale
Auteurs : Esther Cubo ; Glenn T. Stebbins ; Lawrence I. Golbe ; Annette V. Nieves ; Sue Leurgans ; Christopher G. Goetz ; Katie KompolitiSource :
- Movement Disorders [ 0885-3185 ] ; 2000-03.
English descriptors
Abstract
An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.
Url:
DOI: 10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q
Links to Exploration step
ISTEX:5EEA1013FAF101C5C7881953CA3FB838152AADB4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title><author><name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Golbe, Lawrence I" sort="Golbe, Lawrence I" uniqKey="Golbe L" first="Lawrence I." last="Golbe">Lawrence I. Golbe</name><affiliation><mods:affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Nieves, Annette V" sort="Nieves, Annette V" uniqKey="Nieves A" first="Annette V." last="Nieves">Annette V. Nieves</name><affiliation><mods:affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Leurgans, Sue" sort="Leurgans, Sue" uniqKey="Leurgans S" first="Sue" last="Leurgans">Sue Leurgans</name><affiliation><mods:affiliation>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Kompoliti, Katie" sort="Kompoliti, Katie" uniqKey="Kompoliti K" first="Katie" last="Kompoliti">Katie Kompoliti</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5EEA1013FAF101C5C7881953CA3FB838152AADB4</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q</idno><idno type="url">https://api.istex.fr/document/5EEA1013FAF101C5C7881953CA3FB838152AADB4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003072</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title><author><name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Stebbins, Glenn T" sort="Stebbins, Glenn T" uniqKey="Stebbins G" first="Glenn T." last="Stebbins">Glenn T. Stebbins</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Golbe, Lawrence I" sort="Golbe, Lawrence I" uniqKey="Golbe L" first="Lawrence I." last="Golbe">Lawrence I. Golbe</name><affiliation><mods:affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Nieves, Annette V" sort="Nieves, Annette V" uniqKey="Nieves A" first="Annette V." last="Nieves">Annette V. Nieves</name><affiliation><mods:affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Leurgans, Sue" sort="Leurgans, Sue" uniqKey="Leurgans S" first="Sue" last="Leurgans">Sue Leurgans</name><affiliation><mods:affiliation>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author><author><name sortKey="Kompoliti, Katie" sort="Kompoliti, Katie" uniqKey="Kompoliti K" first="Katie" last="Kompoliti">Katie Kompoliti</name><affiliation><mods:affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2000-03">2000-03</date><biblScope unit="vol">15</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="276">276</biblScope><biblScope unit="page" to="279">279</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">5EEA1013FAF101C5C7881953CA3FB838152AADB4</idno><idno type="DOI">10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q</idno><idno type="ArticleID">MDS1010</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Factor analysis</term><term>Motor examination</term><term>Progressive supranuclear palsy</term><term>UPDRS</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Esther Cubo MD</name><affiliations><json:string>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item><json:item><name>Glenn T. Stebbins PhD</name><affiliations><json:string>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item><json:item><name>Lawrence I. Golbe MD</name><affiliations><json:string>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</json:string></affiliations></json:item><json:item><name>Annette V. Nieves MD</name><affiliations><json:string>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</json:string></affiliations></json:item><json:item><name>Sue Leurgans PhD</name><affiliations><json:string>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item><json:item><name>Christopher G. Goetz MD</name><affiliations><json:string>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item><json:item><name>Katie Kompoliti MD</name><affiliations><json:string>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Progressive supranuclear palsy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Factor analysis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Motor examination</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>UPDRS</value></json:item></subject><language><json:string>eng</json:string></language><abstract>An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.</abstract><qualityIndicators><score>3.871</score><pdfVersion>1.3</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>915</abstractCharCount><pdfWordCount>2239</pdfWordCount><pdfCharCount>14186</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>136</abstractWordCount></qualityIndicators><title>Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title><genre><json:string>Serial article</json:string></genre><host><volume>15</volume><pages><total>4</total><last>279</last><first>276</first></pages><issn><json:string>0885-3185</json:string></issn><issue>2</issue><subject><json:item><value>Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2000</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1002/1531-8257(200003)15:2>276::AID-MDS1010>3.0.CO;2-Q</json:string></doi><id>5EEA1013FAF101C5C7881953CA3FB838152AADB4</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/5EEA1013FAF101C5C7881953CA3FB838152AADB4/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/5EEA1013FAF101C5C7881953CA3FB838152AADB4/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/5EEA1013FAF101C5C7881953CA3FB838152AADB4/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><availability><p>John Wiley & Sons, Inc.</p></availability><date>2000</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title><author><persName><forename type="first">Esther</forename><surname>Cubo</surname><roleName type="degree">MD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, 1725 W. Harrison Street, Suite 1106, Chicago, IL 60612, U.S.A.</p></note><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author><author><persName><forename type="first">Glenn T.</forename><surname>Stebbins</surname><roleName type="degree">PhD</roleName></persName><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author><author><persName><forename type="first">Lawrence I.</forename><surname>Golbe</surname><roleName type="degree">MD</roleName></persName><affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</affiliation></author><author><persName><forename type="first">Annette V.</forename><surname>Nieves</surname><roleName type="degree">MD</roleName></persName><affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</affiliation></author><author><persName><forename type="first">Sue</forename><surname>Leurgans</surname><roleName type="degree">PhD</roleName></persName><affiliation>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author><author><persName><forename type="first">Christopher G.</forename><surname>Goetz</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author><author><persName><forename type="first">Katie</forename><surname>Kompoliti</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2000-03"></date><biblScope unit="vol">15</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="276">276</biblScope><biblScope unit="page" to="279">279</biblScope></imprint></monogr><idno type="istex">5EEA1013FAF101C5C7881953CA3FB838152AADB4</idno><idno type="DOI">10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q</idno><idno type="ArticleID">MDS1010</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Progressive supranuclear palsy</term></item><item><term>Factor analysis</term></item><item><term>Motor examination</term></item><item><term>UPDRS</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1999-07-15">Received</change><change when="2000-01-13">Registration</change><change when="2000-03">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/5EEA1013FAF101C5C7881953CA3FB838152AADB4/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Inc.</publisherName><publisherLoc>New York</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="20"><doi origin="wiley" registered="yes">10.1002/1531-8257(200003)15:2<>1.0.CO;2-C</doi><numberingGroup><numbering type="journalVolume" number="15">15</numbering><numbering type="journalIssue">2</numbering></numberingGroup><coverDate startDate="2000-03">March 2000</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="10" status="forIssue"><doi origin="wiley" registered="yes">10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q</doi><idGroup><id type="unit" value="MDS1010"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Article</title><title type="tocHeading1">Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 2000 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="1999-07-15"></event><event type="manuscriptRevised" date="2000-01-05"></event><event type="manuscriptAccepted" date="2000-01-13"></event><event type="firstOnline" date="2001-01-31"></event><event type="publishedOnlineFinalForm" date="2001-01-31"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-01"></event></eventGroup><numberingGroup><numbering type="pageFirst">276</numbering><numbering type="pageLast">279</numbering></numberingGroup><correspondenceTo>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, 1725 W. Harrison Street, Suite 1106, Chicago, IL 60612, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS1010.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="1"></count><count type="referenceTotal" number="14"></count><count type="wordTotal" number="2176"></count></countGroup><titleGroup><title type="main" xml:lang="en">Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title><title type="short" xml:lang="en">Application of the UPDRS in PSP</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Esther</givenNames><familyName>Cubo</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Glenn T.</givenNames><familyName>Stebbins</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Lawrence I.</givenNames><familyName>Golbe</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Annette V.</givenNames><familyName>Nieves</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af3"><personName><givenNames>Sue</givenNames><familyName>Leurgans</familyName><degrees>PhD</degrees></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Christopher G.</givenNames><familyName>Goetz</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au7" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Katie</givenNames><familyName>Kompoliti</familyName><degrees>MD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="US" type="organization"><unparsedAffiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</unparsedAffiliation></affiliation><affiliation xml:id="af3" countryCode="US" type="organization"><unparsedAffiliation>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Progressive supranuclear palsy</keyword><keyword xml:id="kwd2">Factor analysis</keyword><keyword xml:id="kwd3">Motor examination</keyword><keyword xml:id="kwd4">UPDRS</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Application of the UPDRS in PSP</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale</title></titleInfo><name type="personal"><namePart type="given">Esther</namePart><namePart type="family">Cubo</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><description>Correspondence: Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, 1725 W. Harrison Street, Suite 1106, Chicago, IL 60612, U.S.A.</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Glenn T.</namePart><namePart type="family">Stebbins</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Lawrence I.</namePart><namePart type="family">Golbe</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Annette V.</namePart><namePart type="family">Nieves</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sue</namePart><namePart type="family">Leurgans</namePart><namePart type="termsOfAddress">PhD</namePart><affiliation>Department of Preventive Medicine, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Christopher G.</namePart><namePart type="family">Goetz</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Katie</namePart><namePart type="family">Kompoliti</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurological Sciences, Rush‐Presbyterian‐St. Luke's Medical Center, Chicago, Illinois, U.S.A.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>John Wiley & Sons, Inc.</publisher><place><placeTerm type="text">New York</placeTerm></place><dateIssued encoding="w3cdtf">2000-03</dateIssued><dateCaptured encoding="w3cdtf">1999-07-15</dateCaptured><dateValid encoding="w3cdtf">2000-01-13</dateValid><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">1</extent><extent unit="references">14</extent><extent unit="words">2176</extent></physicalDescription><abstract lang="en">An important criterion in scale validation is the demonstration of a stable factor structure. The Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to assess Parkinson's disease (PD). The reliability and applicability of the motor subscale of the UPDRS (UPDRSm) when applied to patients diagnosed with progressive supranuclear palsy (PSP) is unknown. In a sample of 175 patients with PSP, factor analysis revealed five clinically distinct factors: two independent bradykinesia factors (axial/gait and extremities), one rigidity factor, and two independent tremor factors (rest and action). Two items (posture and rest head tremor) did not reach criteria for factor loadings. There was a high degree of internal consistency. These results suggest that UPDRSm is a reliable and applicable scale for assessing most aspects of PSP function as well as severity measures of five clinical disability domains.</abstract><subject lang="en"><genre>Keywords</genre><topic>Progressive supranuclear palsy</topic><topic>Factor analysis</topic><topic>Motor examination</topic><topic>UPDRS</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>276</start><end>279</end><total>4</total></extent></part></relatedItem><identifier type="istex">5EEA1013FAF101C5C7881953CA3FB838152AADB4</identifier><identifier type="DOI">10.1002/1531-8257(200003)15:2<276::AID-MDS1010>3.0.CO;2-Q</identifier><identifier type="ArticleID">MDS1010</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2000 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>John Wiley & Sons, Inc.</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003072 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003072 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:5EEA1013FAF101C5C7881953CA3FB838152AADB4
|texte= Application of the unified Parkinson's disease rating scale in progressive supranuclear palsy: Factor analysis of the motor scale
}}
| This area was generated with Dilib version V0.6.23. |  |